gelsemoxonine: isolated from Gelsemium elegans Benth; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Gelsemium | genus | A plant genus of the family LOGANIACEAE (classified by some botanists as Gelsemiaceae). The sometimes used common name of trumpet flower is also used for DATURA.[MeSH] | Gelsemiaceae | [no description available] |
Gelsemium elegans | species | [no description available] | Gelsemiaceae | [no description available] |
ID Source | ID |
---|---|
PubMed CID | 44583831 |
CHEMBL ID | 524079 |
MeSH ID | M0455350 |
Synonym |
---|
gelsemoxonine |
CHEMBL524079 |
Gelsemoxonine (1) is a Gelsemium alkaloid incorporating an unusual azetidine.
Excerpt | Reference | Relevance |
---|---|---|
"Gelsemoxonine (1) is a Gelsemium alkaloid incorporating an unusual azetidine. " | ( Total synthesis of (±)-Gelsemoxonine. Carreira, EM; Diethelm, S, 2013) | 2.14 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID376637 | Cytotoxicity against human A431 cells after 48 hrs by trypan blue test | 2006 | Journal of natural products, Apr, Volume: 69, Issue:4 | Isolation of gelsedine-type indole alkaloids from Gelsemium elegans and evaluation of the cytotoxic activity of gelsemium alkaloids for A431 epidermoid carcinoma cells. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.41) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |